AVAH · Aveanna Healthcare Holdings, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $647.91M | $621.94M | $589.55M | $559.22M | - | $509.02M | $504.96M | $490.65M | - | $478.01M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | $205.43M | $202.82M | $210.80M | $183.56M | - | $159.70M | $158.27M | $145.85M | - | $147.26M |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $95.79M | $95.40M | $90.07M | $91.39M | - | $88.18M | $87.97M | $87.91M | - | $91.00M |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $3.04M | $2.60M | $2.62M | $2.59M | - | $2.59M | $2.83M | $2.91M | - | $2.96M |
| Operating Income | $69.33M | $53.58M | $80.03M | $51.80M | - | $34.02M | $37.13M | $22.87M | - | ($76.35M) |
| Interest Expense | $29.16M | $35.13M | $36.00M | $36.34M | - | $39.24M | $39.61M | $39.65M | - | $39.60M |
| Income Tax | $3.32M | ($647.0K) | $17.11M | $4.96M | - | $15.51M | ($9.93M) | $12.66M | - | $631.0K |
| Net Income | $41.65M | $14.06M | $27.02M | $5.19M | - | ($42.84M) | $13.91M | ($11.17M) | - | ($102.39M) |
| EPS - Basic | $0.19 | $0.07 | $0.13 | $0.03 | - | ($0.22) | $0.07 | ($0.06) | - | ($0.54) |
| EPS - Diluted | $0.19 | $0.06 | $0.13 | $0.03 | - | ($0.22) | $0.07 | ($0.06) | - | ($0.54) |
Balance Sheet
| Line item | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $189.27M | $145.87M | $100.74M | $71.49M | $84.29M | $78.46M | $47.66M | $42.61M | $43.94M | $48.29M |
| Accounts Receivable | $332.69M | $312.83M | $316.28M | $294.83M | $265.19M | $265.45M | $272.96M | $257.54M | $236.56M | $235.67M |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | $575.30M | $502.60M | $449.92M | $407.62M | $392.67M | $381.37M | $364.00M | $336.04M | $314.89M | $318.25M |
| Total Assets | $2.02B | $1.81B | $1.77B | $1.66B | $1.66B | $1.64B | $1.66B | $1.64B | $1.61B | $1.65B |
| Current Liabilities | $390.43M | $409.69M | $414.23M | $388.31M | $402.17M | $406.04M | $389.15M | $381.93M | $354.76M | $364.30M |
| Long-term Debt | $1.28B | $1.29B | $1.27B | $1.27B | $1.27B | $1.28B | $1.27B | $1.28B | $1.28B | $1.28B |
| Total Liabilities | $1.78B | $1.80B | $1.78B | $1.76B | $1.79B | $1.80B | $1.78B | $1.78B | $1.74B | $1.76B |
| Stockholders' Equity | $240.05M | $9.18M | ($11.99M) | ($100.13M) | ($123.55M) | ($156.44M) | ($118.97M) | ($136.27M) | ($129.57M) | ($105.71M) |
| Retained Earnings | ($1.12B) | ($1.34B) | ($1.35B) | ($1.38B) | ($1.38B) | ($1.41B) | ($1.37B) | ($1.38B) | ($1.37B) | ($1.35B) |
Cash Flow
| Line item | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.35M | - | - | ($8.63M) | - | - | - | ($11.97M) | - | - |
| Investing Cash Flow | ($4.56M) | - | - | ($2.35M) | - | - | - | ($1.31M) | - | - |
| Financing Cash Flow | ($3.78M) | - | - | ($1.81M) | - | - | - | $11.95M | - | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 31.7% | 32.6% | 35.8% | 32.8% | - | 31.4% | 31.3% | 29.7% | - | 30.8% |
| Operating margin | 10.7% | 8.6% | 13.6% | 9.3% | - | 6.7% | 7.4% | 4.7% | - | -16.0% |
| EBITDA margin | 11.2% | 9.0% | 14.0% | 9.7% | - | 7.2% | 7.9% | 5.3% | - | -15.4% |
| Net margin | 6.4% | 2.3% | 4.6% | 0.9% | - | -8.4% | 2.8% | -2.3% | - | -21.4% |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 14.8% | 15.3% | 15.3% | 16.3% | - | 17.3% | 17.4% | 17.9% | - | 19.0% |
| Effective tax rate | 7.4% | -4.8% | 38.8% | 48.8% | - | - | -249.5% | 849.8% | - | - |
| Return on assets | 2.1% | 0.8% | 1.5% | 0.3% | - | -2.6% | 0.8% | -0.7% | - | -6.2% |
| Return on equity | 17.4% | 153.1% | -225.4% | -5.2% | - | 27.4% | -11.7% | 8.2% | - | 96.9% |
| Return on invested capital | 4.2% | 4.1% | 3.9% | 2.3% | - | 2.4% | 3.2% | 1.0% | - | -5.1% |
| Liquidity | ||||||||||
| Current ratio | 1.47 | 1.23 | 1.09 | 1.05 | 0.98 | 0.94 | 0.94 | 0.88 | 0.89 | 0.87 |
| Quick ratio | 1.47 | 1.23 | 1.09 | 1.05 | 0.98 | 0.94 | 0.94 | 0.88 | 0.89 | 0.87 |
| Cash ratio | 0.48 | 0.36 | 0.24 | 0.18 | 0.21 | 0.19 | 0.12 | 0.11 | 0.12 | 0.13 |
| Leverage | ||||||||||
| Debt / Equity | 5.35 | 140.39 | -105.86 | -12.69 | -10.29 | -8.15 | -10.71 | -9.36 | -9.85 | -12.09 |
| Debt / Assets | 0.63 | 0.71 | 0.72 | 0.77 | 0.76 | 0.78 | 0.77 | 0.78 | 0.79 | 0.77 |
| Debt / EBITDA | 17.74 | 22.95 | 15.36 | 23.36 | - | 34.83 | 31.88 | 49.47 | - | - |
| Interest coverage | 2.4x | 1.5x | 2.2x | 1.4x | - | 0.9x | 0.9x | 0.6x | - | -1.9x |
| Equity multiplier | 8.42 | 197.13 | -147.68 | -16.59 | -13.46 | -10.51 | -13.99 | -12.06 | -12.45 | -15.65 |
| Liabilities / Assets | 0.88 | 0.99 | 1.01 | 1.06 | 1.07 | 1.09 | 1.07 | 1.08 | 1.08 | 1.06 |
| Efficiency | ||||||||||
| Asset turnover | 0.32 | 0.34 | 0.33 | 0.34 | - | 0.31 | 0.30 | 0.30 | - | 0.29 |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 187d | 184d | 196d | 192d | - | 190d | 197d | 192d | - | 180d |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 33.6x | 145.8x | 38.6x | 179.0x | - | - | 39.4x | - | - | - |
| P / B | 5.9x | 211.7x | - | - | - | - | - | - | - | - |
| P / S | 2.2x | 3.1x | 1.8x | 2.0x | - | 2.0x | 1.1x | 1.0x | - | 0.5x |
| EV / EBITDA | 34.7x | 55.0x | 26.9x | 42.4x | - | 60.0x | 44.3x | 66.4x | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 15.9% | 22.2% | 16.8% | 14.0% | - | 6.5% | 7.0% | 5.2% | - | 7.9% |
| Revenue CAGR (3y) | 11.6% | 12.0% | 10.0% | 7.5% | - | 11.6% | 5.0% | 5.6% | - | - |
| Revenue CAGR (5y) | 9.2% | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | 11.9% | 27.0% | 33.2% | 25.9% | - | 8.4% | 1.9% | 1.0% | - | 9.4% |
| Operating income growth (YoY) | 33.8% | 57.5% | 115.6% | 126.5% | - | - | -1.0% | 29.6% | - | - |
| Net income growth (YoY) | 702.1% | - | 94.3% | - | - | 58.2% | -45.7% | 65.1% | - | - |
| EPS growth (YoY) | 533.3% | - | 85.7% | - | - | 59.3% | -46.2% | 64.7% | - | - |
| EPS CAGR (3y) | - | -22.7% | - | -40.2% | - | - | 91.3% | - | - | - |
| EPS CAGR (5y) | -6.8% | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | - | - | 89.9% | 26.5% | 4.6% | -48.0% | -1665.9% | -280.0% | -1953.4% | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2026-01-03.
Business segments
$2.43B totalPrivate Duty Services$2.00B · 82.2%
Home Health And Hospice$248.56M · 10.2%
Medical Solutions$183.50M · 7.5%
Peer comparison
Same SIC group: Services-Home Health Care Services
Comparing Aveanna Healthcare Holdings against the 5 most active filers in the same SIC group.